Search

Your search keyword '"Lundvall, Lene"' showing total 466 results

Search Constraints

Start Over You searched for: Author "Lundvall, Lene" Remove constraint Author: "Lundvall, Lene"
466 results on '"Lundvall, Lene"'

Search Results

1. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.

2. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

3. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

4. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

5. No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival

6. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

7. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

8. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer

9. Evidence of a genetic link between endometriosis and ovarian cancer

10. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

11. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk.

12. A 3D system to model human pancreas development and its reference single-cell transcriptome atlas identify signaling pathways required for progenitor expansion

14. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer

15. Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.

16. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer.

17. Genome-wide significant risk associations for mucinous ovarian carcinoma (vol 47, pg 888, 2015)

18. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

19. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

20. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.

21. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.

22. Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

23. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.

24. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

25. Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

26. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10.

27. Tracing the origin of adult intestinal stem cells

28. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

29. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.

30. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

31. Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium

32. Data from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

33. Supplementary Tables 1 - 4 from Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome

34. Data from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

35. Data from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

36. Data from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

37. Supplementary Tables S1-6, Figures S1-2 from Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk

38. Supplementary Figures 1-5, Tables 1-8 from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

39. Supplementary Tables 1-7 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

40. Supplementary Figures 1-4 from Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality

41. Supplementary Tables 1 through 3 from Variation in NF-κB Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

42. Data from Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

43. Data from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

44. Supplementary Tables 1 - 5 from Risk of Ovarian Cancer and the NF-κB Pathway: Genetic Association with IL1A and TNFSF10

45. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

46. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

48. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

49. European Society of Gynaecological Oncology (ESGO) Guidelines for Ovarian Cancer Surgery

Catalog

Books, media, physical & digital resources